Adrenal Cancer News
Links to treatment and research news, and stories of courageU-M startup company secures license, funding to test potential drugs aimed at endocrine disorders
From the blog, Put Up Your Umbrella: Finding Shelter in the Storm of Grief, read An Open Letter to Dr. Gary D. Hammer (posted 5/20/2015).
Congratulations to Mark Cohen, M.D., who together with Anna Schwendeman, Ph.D., was recently awarded MTRAC FFMI funding for their work on a novel targeted therapy drug for adrenal cancer. For more information, please see the article in the Michigan Daily.